Future Watch: Gene & Cell Therapy
A Revolution In Medicine And Healthcare Blog
Current Blog Category: Gene Therapy Investing
The Death of the Regulatory Barrier to Better Medicine
Written by Jeff Galvin, CEO of American Gene Technologies® The birth of high-value therapeutics and cures Does the development of effective drugs have to be incredibly expensive? Maybe not anymore. There is a new type of drug development emerging: Gene Therapy. The hallmark of gene therapy…
Read More
What Impact Did the Stock Market Crash Have on Biotech Stocks?
Contributing Author John Vandermosten, Senior Biotechnology Analyst Examining events of the past can give us a sense of what to expect in the periods ahead. And despite the omnipresent warning that “past performance is not indicative of future results” we will share some historical trends on…
Read More
Gene Therapy Technology – Reprogramming The Human Computer
Subscribe to our YouTube Channel “We are at the beginning of the technology curve in pharmaceuticals.” Jeff Galvin, CEO of American Gene Technologies (AGT), explains his ascent into the biotechnology drug development field after working closely with computers in Silicon Valley for a large part…
Read More
HIV IMMUNITY Dr. Hardy Shares the Possibilities of Gene Therapy
Subscribe to our YouTube Channel Contrary to antiretroviral drugs, gene therapy could be used to give the human body immunity to HIV. Dr. David Hardy, a member of American Gene Technologies (AGT)’s HIV Scientific Advisory Board, tells his story of his lifelong commitment to mitigate…
Read More
Using Gene Therapy to Cure Diseases, Irene Tennant, VP of AGT
Irene Tennant, the head of clinical development and regulatory affairs at AGT, speaks about her role in the development of gene and cell therapies to treat human diseases. She works to progress potential therapies into the clinic, and ultimately to the bedsides of thousands of…
Read More
Progression of a Gene Therapy Company, Jeff Galvin, CEO and Irene Tennant, VP of AGT
In this video, Jeff Galvin and Irene Tennant have a conversation about their work at American Gene Technologies (AGT), a gene therapy company, built to cure diseases that were previously thought of as incurable. The mission statement of the company is to “reduce human suffering…
Read More
About Gene Therapy, Jeff Galvin, CEO of AGT
In this video, Jeff Galvin explains how American Gene Technologies (AGT) uses genetic modifications in the body to change how viral diseases interact with the immune system. Jeff Galvin, CEO of AGT, explains how he believes gene therapy is developing in a similar way…
Read More
Cell and Gene Therapy Approach, Jeff Galvin, CEO of AGT
Gene therapy is accelerating at an incredibly fast and impressive rate. AGT is at the forefront of this progress, fuelling the gene therapy market. Jeff Galvin, CEO of AGT, explains how he believes gene therapy is developing in a similar way to that of…
Read More
Cell Therapy Manufacturing, C. David Pauza, Ph.D., CSO of AGT
This video explains the ins and outs of cell therapy. Dr. C. David Pauza, Chief Science Officer of American Gene Technologies, explains how one tiny dot on a cell, a virus, can kill a person, but this dot can be changed from the infectious root…
Read More
Benefits of FDA Orphan Drug Designation: What You Need to Know
by Irene TennantVP of Clinical Product Development and Regulatory Affairs Developing treatments for rare diseases has many challenges. These challenges are different and, in many ways, more complex than what is experienced during development of a drug intended for a larger patient population. The complexities…
Read MoreSubscribe to Receive our Blog Updates
Subscribe to our blog updates to be notified when we release new content!
